MedDataX Logo

Prevalence of Metabolic Syndrome in Atahualpa

NCT ID: NCT01770054

Last Updated: 2013-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

517 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-01-31

Study Completion Date

2013-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Regional Observation of the Metabolic Syndrome

NCT00874952

Metabolic Syndrome
COMPLETED

Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)

NCT00416741

Metabolic Syndrome
COMPLETED

Metabolic Syndrome Prevalence Study

NCT02379702

Metabolic Syndrome
COMPLETED

Metabolic Syndrome and Related Diseases in Healthcare Workers

NCT06543706

Metabolic Syndrome X Diabetes Mellitus Type 2 Hypertension +4 more
COMPLETED

Multinational Point Prevalence Study on the Management of Diabesity in Hospitals

NCT06680674

Diabetes Mellitus Obesity
ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

obtention of a blood sample

all Atahualpa residents aged 40 years or more

obtention of a blood sample

Intervention Type OTHER

a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

obtention of a blood sample

a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Atahualpa resident aged 40 years or more

Exclusion Criteria

* non-consenting persons
Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Clínica Kennedy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Oscar H. Del Brutto, MD

Rsearch Proffesor, Universidad de Especialidades Espiritu Santo

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Oscar H Del Brutto, MD

Role: PRINCIPAL_INVESTIGATOR

Universidad de Especialidades Espiritu Santo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Center of Health

Atahualpa, Santa Elena, Ecuador

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ecuador

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

001-2013-01

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

TAP 001-2013

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of a Low Glycemic Index on Metabolic Syndrome
NCT02356952 COMPLETED NA
Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis
NCT01119404 UNKNOWN
Metabolic Syndrome Diagnosis and Treatment for Adults of Low Socioeconomic Status Communities
NCT02459249 UNKNOWN NA
Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain
NCT00651001 COMPLETED
Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
NCT00408824 UNKNOWN
Prevalence of Metabolic Syndrome in a Maintenance Hemodialysis Population
NCT01176630 COMPLETED
Prospective Metabolic Indicator Study
NCT03588117 COMPLETED
Impact of Interventions With a Diet and Exercise on the Cardio-metabolic Status in Multi-risk Population
NCT03701425 UNKNOWN NA
MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study
NCT07312136 ENROLLING_BY_INVITATION
Risk Factor Analysis for Developing Metabolic Syndrome in Korean Adults
NCT01594710 COMPLETED
Cardiovascular Risk Evaluation in Clinical Practice in Metabolic Syndrome Patients
NCT00171548 COMPLETED
Remote Physical Activity Monitoring in Individuals With Metabolic Syndrome
NCT05592704 COMPLETED NA
Metabolic Phenotyping in Humans
NCT01298375 UNKNOWN
Utilizing a Promotora Model for Rural Adult Hispanics Diagnosed With Metabolic Syndrome: A Clinical Trial
NCT01839864 WITHDRAWN NA
Investigating the Possible Link Between Habitual Diet, Physical Activity, Sleeping Patterns, Obesity Status and Age With Gut Bacterial Composition, Gut Barrier Function, Metabolic Endotoxemia, Systemic Inflammation and Glycaemic Control.
NCT03864107 UNKNOWN
Metabolic Syndrome Observation on a Regional Basis
NCT00933010 COMPLETED
Use of Computers to Prevent Metabolic Syndrome
NCT01713465 UNKNOWN NA
CArdioMetabolism and Atherosclerotic PlaqUe progreSsion
NCT05117424 RECRUITING
The Effect of Feedback on Physical Activity Surveillance Using Wearable Device-Smartphone Application for Resolution of Metabolic Syndrome in Aged 60 or Older
NCT05830552 COMPLETED NA
Effect of the SCL16A11 Risk Haplotype on Treatments to Prevent Type 2 Diabetes
NCT05990205 COMPLETED PHASE2
Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)
NCT01114763 COMPLETED
Type 2 Diabetes and Associated Factors in Mexico
NCT07248891 ENROLLING_BY_INVITATION
Frequency of Metabolic Syndrome in Down Syndrome Patients
NCT00864461 COMPLETED
The Effectiveness of Intermittent Fasting, Caloric Restriction and Physical Activity On Metabolic Syndrome
NCT07181655 RECRUITING NA
Biomarkers of Metabolic Syndrome and Prediabetes
NCT01086137 COMPLETED